PUVA‐induced lymphocyte apoptosis: Mechanism of action in psoriasis
- 13 February 1999
- journal article
- research article
- Published by Wiley in Photodermatology, Photoimmunology & Photomedicine
- Vol. 15 (1) , 22-27
- https://doi.org/10.1111/j.1600-0781.1999.tb00048.x
Abstract
Psoralen plus ultraviolet A (PUVA), utilizing oral 8‐methoxypsoralen (8‐MOP), is a widely utilized and effective treatment for psoriasis vulgaris. Previous studies have suggested that PUVA's mechanism of action in psoriasis is a result of its direct lymphotoxic effects. Trimethylpsoralen (TMP), a potentially safer compound, has been found to be effective in psoriasis during bath water delivery. In this study we examined the relative anti‐lymphocytic effects of TMP and 8‐MOP through both flow cytometry and tissue analysis on lesional skin during clinical treatment. Based on FACS analysis on phytohemagglutinin‐activated lymphocytes, we found TMP to be nearly 10,000 fold more lymphotoxic compared to 8‐MOP. In addition, lymphocytes treated with 8‐MOP or TMP with UVA displayed DNA degradation patterns typical of apoptotic cell death. These findings were consistent with our investigation of treated psoriatic skin, with virtual elimination of epidermal CD3+ T‐cells following bath water treatment with TMP or 8‐MOP. These results support the theory that the therapeutic effects of PUVA stem from its toxic effects on activated lymphocytes. If further investigation supports TMP's lack of carcinogenicity, this potent lymphotoxic treatment may prove to be one of the safest and most effective treatments for psoriasis.Keywords
This publication has 23 references indexed in Scilit:
- Apoptosis Induction by Ultraviolet Light A and Photochemotherapy in Cutaneous T-Cell Lymphoma: Relevance to Mechanism of Therapeutic ActionJournal of Investigative Dermatology, 1996
- PUVA Treatment Selectively Induces a Cell Cycle Block and Subsequent Apoptosis in Human T‐LymphocytesPhotochemistry and Photobiology, 1996
- Successful ultraviolet B treatment of psoriasis is accompanied by a reversal of keratinocyte pathology and by selective depletion of intraepidermal T cells.The Journal of Experimental Medicine, 1995
- PUVA bath therapy strongly suppresses immunological and epidermal activation in psoriasis: a possible cellular basis for remittive therapy.The Journal of Experimental Medicine, 1994
- PUVA and cancer: a large-scale epidemiological studyThe Lancet, 1991
- Early dermato‐pathological signs during bath‐puva therapyThe Journal of Pathology, 1990
- Non-Melanoma Skin Cancer Occurring in Patients Treated With PUVA Five to Ten Years After First TreatmentJournal of Investigative Dermatology, 1988
- Antipsoriatic, erythematogenic, and Langerhans cell marker depleting effect of bath—psoralens plus ultraviolet A treatment: Comparison of 8-methoxypsoralen and trimethylpsoralen photos ensitizationJournal of the American Academy of Dermatology, 1988
- Comparison of Synthetic Psoralen Derivatives and 8‐MOP in the Inhibition of Lymphocyte ProliferationaAnnals of the New York Academy of Sciences, 1985
- Trioxsalen bath plus UVA effective and safe in the treatment of psoriasisBritish Journal of Dermatology, 1978